Macrophage and angiogenesis intensity within proliferative non neoplastic and  neoplastic oral lesions

Janti Sudiono; Barnabas Howuk; Cindy Fransisca

doi:10.24198/pjd.vol30no3.16851

Macrophage and angiogenesis intensity within proliferative non neoplastic and neoplastic oral lesions

Janti Sudiono, Barnabas Howuk, Cindy Fransisca

Abstract

The most common chronic inflammation involved dental and oral tissue is gingival polyp, pulp polyp, and fibroma that are proliferative non neoplastic and neoplastic condition. Chronic inflammation will induce cells and vascular proliferation as well as biological nature lesion. Previous study revealed that increase macrophage followed by increase angiogenesis intensity. Increase angiogenesis or vascular proliferation indicates progressive growth in form of proliferative non neoplastic or neoplastic disease outside of their easily bleeding clinical features. This study evaluated macrophage and angiogenesis intensity and their correlation within such oral lesions. Samples used are of oral mucosa excision with clinical diagnose of gingival polyp (n=3); pulp polyp (n=3); and fibroma (n=3). Macrophage was detected using immunostaining with CD68 antibody resulted in brown staining cell membrane under light microscope while angiogenesis intensity evaluated as number of blood vessels. The results showed there was mild positive correlation of angiogenesis intensity and CD68⁺ as macrophage marker with r=0.31. The angiogenesis intensity showed significant differences (p<0.05) with the highest was in pulp polyp (12.00) followed by fibroma (11.81) and gingival polyp (9.67), however there was no significant difference between non neoplastic lesion (pulp polyp) and neoplastic lesion (fibroma). The CD68+ expression showed no significant differences (p=0.102>0.05) with the highest was in fibroma (51.32±31.64%) followed by non neoplastic pulp polyp (45.82±15.94%) and gingival polyp (29.98±13.51%). This result was in accordance with the biological properties of lesions from the aspect of angiogenesis and macrophage intensity that can be used as parameter for determining the growth and prognosis of lesion.

Keywords

Angiogenesis, Macrophage, CD68, Oral proliferative non neoplastic and neoplastic lesion.

Full Text:

PDF

References

Rouby DH. Association of macrophages with angiogenesis in oral verrucous and squamous cell carcinomas. Journal Oral Pathology Med. 2010; 39: 559-64.

Flanagan M. The physiology of wound healing. Journal of Wound Care. June, 2000; 9(6): 299-300

Neville BW, Damm DD, Allen CM, Chi AC. Oral and maxillofacial pathology. China: Elsevier. 2009: 127-38

Grossman LI, Oliet S, Del Rio CE. Endodontic practice. USA: Lea and Febiger. 2000: 77-9.

Patil S, Rao RS, Sharath S, and Agarwal A. True Fibroma of Alveolar Mucosa. Case reports in dentistry; 2014. Article ID 904098, 3 pages

Nucera S, Biziato D, Palma MD. The interplay between macrophages and angiogenesis in development tissue injury and regeneration. Int. J. dev. Biol. 2010; 55:495-503.

Sastroasmoro S, Ismael S. The principle of clinical research methodology. 3rd Ed. Jakarta: Sagung Seto; 2014: 308.

Tanusantoso A. Correlation of epithelial cell proliferation on gingival polyp, gingival hypertrophy, and papilloma with Ki-67 gene expression (skripsi). Jakarta: Faculty of Dentistry, Trisakti University; 2013.

Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. Macrophages and Angiogenesis. J of Leukocyte Bio. 1994; 55:410-7.

Prabhu V, Kumar S, Gopal V. A Review on Angiogenesis Assays. J Pharm Sci. 2010; 2(3): 159-64.

Sudiono J, Kurniadhi B, Hendrawan A, Djimantoro B. Pathology. Jakarta: EGC. 2003: 83.

Polverini PJ. Angiogenesis in health and disease: insight into basic mechanisms and therapeutic opportunities. J Dental Edu. 2002; 66: 962-75.

Jones A, Harris AL. New Developments in Angiogenesis: A Major Mechanism for Tumor Growth and Target for Therapy. Cancer J Sci Am. 1998; 4(4): 209-17.

Wynn T, Barron L. Macrophages: Master Regulators of Inflammation and Fibrosis. Semin Liver Dis. 2010; 30(3):245-57.

Price SA, Wilson LM. Pathophysiology, clinical concepts of disease processes. Memphis: Mosby year book. 1992: 43-6.

Chandrasoma P, Taylor CR. Concise pathology. Appleton and Lange. 2006: 6, 27, 78-85.

Landskron G, Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. Chronic inflammation and cytokines in the tumor microenvironment. Journal of immunology research. Vol 2014 (2014). Article ID 149185, 19 pages.

Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. AACR journal. 2006; 4:221-33.

Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Oxford journals. 2009; 30:1073-81.

Rakoff S. Why cancer and inflammation? Yale journal of biology and medicine. 2007; 79:3-4.

Solinas G, Germano G, Mantovani A, Allavena P. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol. 2009 Nov; 86(5):1065-73. doi: 10.1189/jlb.0609385. Epub 2009 Sep 9.

Ohnishi S, Ma N, Thanan R, Pinlaor, Hammam O, Murata et al. DNA damage in inflammation-related carcinogenesis and cancer stem cells. Oxidative medicine and cellular longevity. Vol 2013 (2013). Aritcle ID 387014, 9 pages.

Robbins S, Kumar V, Cotran R. Robbins basic pathology. Vol.1, 7th Ed. New York: Elsevier; 2010: 56-61. 76-83; 185-191.

Lorenz HP, Longaker MT. Wounds: biology, pathology, and management. In: Surgery basic science and clinical evidence. Editor: Norton JA. New York. 2011; 1: 221-37

Wynn T. Integrating Mechanism of Pulmonary Fibrosis. The Journal of Experimental Medicine. 2011; 208(7):1338-50.

Coussens LM, Werb Z. Inflammation and cancer. USA: HHS Public access; 2002; 420(6917):860-7.

Sudiono J, Thalib S. Angiogenesis Intensity within Benign and Malignant Oral Mucosa Epithelial Tumor. MCBS Mol Cell Biomed Sci. 2018; 2(1):23-7. Print ISSN: 2527-4384, Online ISSN: 2527-3442

DOI: https://doi.org/10.24198/pjd.vol30no3.16851